Trial Profile
Dulaglutide and insulin glargine in patients with type 2 diabetes mellitus and chronic kidney disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jan 2018
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary) ; Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 11 Jan 2018 New trial record
- 08 Dec 2017 Results presented at the 2017 Congress of the International Diabetes Federation